AMGN) — Amgen Inc. (NASDAQ

Lester Mason
January 13, 2018

The stock had a trading volume of 2,542,567 shares, compared to its average volume of 2,506,800. The company has market cap of $1.17 billion. It closed at $37.95 lastly. (NASDAQ:VTVT) has declined 0.20% since January 12, 2017 and is downtrending. It has outperformed by 52.99% the S&P500. Badgley Phelps & Bell Inc. boosted its position in Amgen by 76.9% in the second quarter. (AMGN) by 2.39% based on its latest 2017Q3 regulatory filing with the SEC. The Selway Asset Management holds 2,910 shares with $543,000 value, down from 27,385 last quarter. The fund invests in the public equity markets across the globe. The stock, after opening at $182.86, hit $181.96 through the close by scoring -0.49%. After $3.27 actual earnings per share reported by Amgen Inc. for the previous quarter, Wall Street now forecasts -7.65% negative EPS growth. It has underperformed by 11.43% the S&P500.

In recent action, Amgen Inc. One equities research analyst has rated the stock with a sell rating, fourteen have given a hold rating and ten have given a buy rating to the company's stock. Therefore 48% are positive. Amgen Inc. had 74 analyst reports since August 3, 2015 according to SRatingsIntel. As per Monday, September 7, the company rating was upgraded by UBS.

In other news, EVP Sean E. Harper sold 1,525 shares of the business's stock in a transaction on Tuesday, December 12th. As per Friday, October 13, the company rating was maintained by Barclays Capital. Citigroup has "Neutral" rating and $172 target. Mizuho reissued a "buy" rating and issued a $198.00 price objective (up previously from $183.00) on shares of Amgen in a research report on Thursday, September 28th. (NASDAQ:AMGN) rating on Friday, October 6. Piper Jaffray has "Buy" rating and $193.0 target.

"TRADEMARK VIOLATION WARNING: "$3.04 Earnings Per Share Expected for Amgen, Inc. (NASDAQ:AMGN) earned "Market Perform" rating by Bernstein on Wednesday, June 29. On Friday, July 21 the stock rating was maintained by Oppenheimer with "Buy". Parametric Port Associates Limited Liability Company, a Washington-based fund reported 73,392 shares. It also reduced its holding in Apple Inc (NASDAQ:AAPL) by 6,889 shares in the quarter, leaving it with 14,069 shares, and cut its stake in Fortinet Inc (NASDAQ:FTNT). $283,574 worth of Amgen Inc. The company is expected to announce its next earnings report on Thursday, February 1st. During the same period a year ago, the firm earned $3.02 earnings per share. AMGN's profit would be $2.19B giving it 15.06 P/E if the $3.02 EPS is correct. Moreover, Perritt Capital Management Inc has 0.51% invested in the company for 68,693 shares.


Investors sentiment decreased to 0.99 in Q3 2017. Its up 0.25, from 1.91 in 2017Q2. It dropped, as 58 investors sold AMGN shares while 511 reduced holdings. Hermes Investment Management Ltd. raised its position in Amgen by 23.5% in the third quarter. The medical research company reported $3.27 earnings per share for the quarter, topping the consensus estimate of $3.11 by $0.16. Berkshire Asset Mngmt Ltd Liability Corp Pa invested 2.45% of its portfolio in Amgen Inc. Finally, Bank of America lifted their target price on shares of Amgen to $210.00 and gave the stock a "buy" rating in a report on Thursday, October 5th. Jacobus Wealth Mgmt owns 2,620 shares for 0.13% of their portfolio. (NASDAQ:AMGN) for 7,740 shares. Murphy Capital Management has invested 0.31% in Amgen Inc. (NASDAQ:AMGN) for 4,015 shares. (NYSE:DLB). Brown Brothers Harriman And holds 0% of its portfolio in Dolby Laboratories, Inc. (NASDAQ:AMGN) has "Buy" rating given on Tuesday, July 11 by Jefferies. The institutional investor held 135,187 shares of the multi-sector company at the end of 2017Q3, valued at $7.78 million, up from 120,314 at the end of the previous reported quarter. Pnc Financial Serv Grp holds 0.41% of its portfolio in Amgen Inc. The Connecticut-based Ellington Management Group Llc has invested 0.1% in the stock. Nantahala Cap Mngmt Limited Liability Co reported 2.18% stake. Wms Prtnrs Lc holds 0.14% or 6,231 shares.

Since January 1, 0001, it had 0 insider buys, and 2 selling transactions for $553,240 activity. (NASDAQ:AMGN) earned "Outperform" rating by RBC Capital Markets on Friday, July 31. Therefore 100% are positive. vTv Therapeutics Inc had 3 analyst reports since August 24, 2015 according to SRatingsIntel. Jefferies has "Buy" rating and $200.0 target. DA Davidson initiated the shares of MFSF in report on Thursday, July 21 with "Underperform" rating. (NYSE:BKS) by 55,060 shares to 116,442 shares, valued at $884.96 million in 2017Q3, according to the filing. Renaissance Technologies LLC increased its stake in shares of Amgen by 40.9% during the second quarter.

Analysts await Bridgepoint Education, Inc. Private Asset Management reported 0.12% in Amgen Inc. Its down 0.16, from 1.15 in 2017Q2. It increased, as 5 investors sold MFSF shares while 10 reduced holdings. 33 funds opened positions while 70 raised stakes. Kayne Anderson Rudnick Inv Limited Liability Corp holds 0.06% in Amgen Inc. Hood River Capital Mgmt Ltd Llc stated it has 0.72% in TrueCar, Inc. Capital Ww Invsts has invested 0.01% in Dolby Laboratories, Inc. Bb&T holds 92,111 shares. Oakworth Capital owns 734 shares for 0.03% of their portfolio. 16,970 are owned by Loudon Ltd Co. Victory Capital Inc has invested 0% in Dolby Laboratories, Inc. (NASDAQ:AMGN). Moreover, Cubist Systematic Strategies Limited Com has 0.03% invested in Amgen Inc. HYPMY's SI was 9,600 shares in January as released by FINRA. (NASDAQ:MFSF). Sei Investments has 0% invested in MutualFirst Financial, Inc. 5,121 were accumulated by Carret Asset Management Limited Liability.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER